6 completed. 4 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Ortho Cyclen: new trials by email Literature Review of Ortho Cyclen trials Research Report on Ortho Cyclen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Elagolix for Fertility Enhancement Clinical Trial Elagolix, Ortho Cyclen - Endometriosis, Unexplained Infertility | Phase 2 | Completed | Wake Forest University Health Sciences | 10 | 2022-01-15 | 2024-07-26 |
| Study of Combined Oral Contraceptive Effects in Female Subjects BMS-955176, Ortho Cyclen - Infection, Human Immunodeficiency Virus | Phase 1 | Completed | ViiV Healthcare | 46 | 2014-06-02 | 2018-04-17 |
| A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different Facilities Norgestimate /Ethinyl estradiol tablets (NGM/EE) (Wet Process), Norgestimate /Ethinyl estradiol tablets (NGM/EE) (Dry Process) - Healthy | Phase 1 | Completed | Janssen Research & Development, LLC | 101 | 2013-06-01 | 2014-10-03 |
| A Study of LY2216684 in Healthy Females LY2216684, Ortho Cyclen, Placebo - Depressive Disorder, Major | Phase 1 | Completed | Eli Lilly and Company | 20 | 2011-06-01 | 2018-10-23 |
| Drug Interaction - Oral Contraceptive Ortho Tri-Cyclen LO, Ortho Cyclen, Ortho Cyclen + Efavirenz - HIV Infections | Phase 1 | Completed | Bristol-Myers Squibb | 28 | 2006-12-01 | 2011-04-14 |
| Birth Control Pill vs Birth Control Patch Study Ethinyl estradiol and norgestimate, Ethinyl estradiol and norelgestromin - Venous Thrombosis | Not applicable | Completed | University of Vermont | 24 | 2003-04-01 | 2007-11-07 |
Acquired Immunodeficiency Syndrome (1) · Depressive Disorder, Major (1) · Endometriosis (1) · HIV Infections (1) · Infections (1) · Venous Thrombosis (1)
Bristol-Myers Squibb (1) · Eli Lilly and Company (1) · Janssen Research & Development, LLC (1) · University of Vermont (1) · ViiV Healthcare (1) · Wake Forest University Health Sciences (1)
United States (3) · Netherlands (1)
Bruce A Lessey, MD, PhD (1) · Julia V Johnson, MD (1)
2014 (1)